Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Pharming Group NV (PHGUF) had Revenue of $297.20M for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$297.20M
Net Income	$-11.84M
Cost of Goods Sold	$35.40M
Gross Profit	$261.80M
Operating Expenses	$305.82M
Operating Income	$-8.62M
Non-Operating Income/Expense	$0.13M
Pre-Tax Income	$-8.49M
Normalized Pre-Tax Income	$-8.49M
Income after Taxes	$-11.84M
Income from Continuous Operations	$-11.84M
Consolidated Net Income/Loss	$-11.84M
Normalized Income after Taxes	$-11.84M
EBIT	$-8.62M
EBITDA	$7.45M
Weighted-Average Shares Outstanding (Basic)	671.35M
Weighted-Average Shares Outstanding (Diluted)	785.41M
Earnings per Share (EPS) (Basic)	$-0.02
Earnings per Share (EPS) (Diluted)	$-0.02
Balance Sheet Financials
Current Assets	$278.44M
Property, Plant, and Equipment	$7.75M
Long-Term Assets	$121.56M
Total Assets	$399.99M
Current Liabilities	$73.80M
Long-Term Debt	$105.12M
Long-Term Liabilities	$105.12M
Total Liabilities	$178.92M
Common Equity	$221.06M
Tangible Shareholders Equity	$160.02M
Shareholders Equity	$221.06M
Common Shares Outstanding	680.31M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-1.79M
Cash Flow from Investing Activities	$31.62M
Cash Flow from Financial Activities	$-34.41M
Beginning Cash	$61.74M
End Cash	$54.94M
Increase/Decrease in Cash	$-6.80M
Stock-Based Compensation	$11.25M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.77
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.32
Debt to Equity Ratio	0.51
Gross Margin	88.09%
Operating Margin	-2.90%
EBIT Margin	-2.90%
EBITDA Margin	2.51%
Pre-Tax Profit Margin	-2.86%
Profit Margin	-3.98%
Free Cash Flow	$-2.58M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.74
Inventory Turnover	0.64
Receiveable Turnover	5.42
Days Sales in Receivables	67.33
Return on Equity	-5.36%
Return on Tangible Equity	-7.40%
Return on Assets	-2.96%
Return on Investments	-3.63%
Book Value Per Share	$0.32
Free Cash Flow per Share	$-0.00
Operating Cash Flow per Share	$-0.00

Data from Zacks Investment Research, Inc.